GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
Clinical trial NCT03733587 · COMPLETED
Trial details
- NCT number
- NCT03733587
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2020-04-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.